It is almost 20 years since Crombie, Davies and Macrae identified the major part that surgery plays in the development of chronic pain, 1 which led to the first definition of chronic post-surgical pain (CPSP). 2 Since then the definition has undergone some refinement, 3 whereby the diagnosis of CPSP now requires the following criteria:
• The pain develops after a surgical procedure or increases in intensity after the surgical procedure. • The pain should be of at least 3-6 months' duration and significantly affect the health-related quality of life (HR-QOL). • The pain is either a continuation of acute postsurgery pain or develops after an asymptomatic period. • The pain is either localised to the surgical field, projected to the innervation territory of a nerve situated in the surgical field, or referred to a dermatome (after surgery in deep somatic or visceral tissues). • Other causes of the pain should be excluded, for example, infection or continuing malignancy in cancer surgery.
In this Global Year against Pain after Surgery, it feels timely to provide an update on the current knowledge around CPSP. Our understanding has increased in the past two decades to acknowledge the many factors involved in the development of CPSP and the subsequent impact on a patient's quality of life. Unsurprisingly, the risk factors are many and intertwined, sometimes leaving more questions than answers in how best to predict or manage those at highest risk of progressing to a chronic pain state.
The main risk factors of type of surgery, nerve handling during surgery, pre-and post-operative psychological factors, pre-existing chronic pain and severe acute pain in the immediate post-operative period were all identified early as having significant influence. More recently, acute neuropathic pain, pre-operative opioid use, pain trajectories, genetic and epigenetic markers and inflammatory processes have attracted more attention.
Patricia Lavand'homme's title for her overview of CPSP 'Why me?' is pertinent. Broadly speaking, when we consider which patients might develop CPSP, epidemiologists, psychologists and pain specialists have helped identify the who; geneticists and psychologists the why; basic scientists the how; surgeons, anaesthetists and psychologists the what (might make a difference); and acute and chronic pain specialists the when.
However, the frustration of CPSP is that little has developed in terms of prevention. It is hardly surprising that studies into pharmacological interventions administered to all peri-operative patients to prevent the development of CPSP have not shown great success. 4 With such a complex interplay of variables, a simple drug solution was always unlikely. A real success, however, is that surgeons are now involved in the discussion of CPSP and recognise it as one of the most important complications of surgery, allowing patients to have a fuller informed consent process for their operation.
As we move forward, prevention of CPSP remains a goal. Large scale, carefully designed studies will allow more accurate risk stratification of patients; the setting up of transitional pain services will enable early interventions for post-operative patients showing worrying pain trajectories or experiencing acute neuropathic pain; and, as Aliza Weinrib and colleagues discuss, we shall establish better ways of improving psychological flexibility in those at risk of chronification.
In May this year, the Acute Pain Special Interest Group of the British Pain Society organised a satellite meeting before this year's Annual Scientific Meeting. It was titled 'Persistent Post-Surgical Pain: Challenges and Approaches' and had a veritable smorgasbord of specialities represented in both the invited speakers and the audience, with basic science, epidemiology, surgery, anaesthesia, psychology, genetics and acute and chronic pain discussed. This issue of the British Journal of Pain continues the multidisciplinary theme.
It is this collaborative working that the pain community does particularly well and which will provide the best chance of reliably identifying those at risk of 
